Back to top
Top

Use of High-Risk Medications in Older Adults

General eCQM Information

CMS Measure ID CMS156v10
NQF Number Not Applicable
Measure Description

Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class. Three rates are reported.

1. Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class.

2. Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class, except for appropriate diagnoses.

3. Total rate (the sum of the two numerators divided by the denominator, deduplicating for patients in both numerators).

Initial Population Patients 65 years and older who had a visit during the measurement period
Denominator Statement

Equals Initial Population

Denominator Exclusions

Exclude patients who are in hospice care for any part of the measurement period.

Exclude patients receiving palliative care during the measurement period.

Numerator Statement

Rate 1 : Patients with at least two orders of high-risk medications from the same drug class.

Rate 2: Patients with at least two orders of high-risk medications from the same drug class (i.e., antipsychotics and benzodiazepines).

Total rate (the sum of the two previous numerators, deduplicated).

Numerator Exclusions

Rate 2: For patients with two or more antipsychotic prescriptions ordered, exclude patients who have a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder on or between January 1 of the year prior to the measurement period and the Index Prescription Start Date (IPSD) for antipsychotics.

For patients with two or more benzodiazepine prescriptions ordered, exclude patients who have a diagnosis of seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, or severe generalized anxiety disorder on or between January 1 of the year prior to the measurement period and the IPSD for benzodiazepines.

Denominator Exceptions

None

Measure Steward National Committee for Quality Assurance
Domain Patient Safety
Measure Scoring Proportion
Measure Type Process
Improvement Notation

Lower score indicates better quality

Guidance

The intent of the measure is to assess if the patient has been ordered at least two of the same high-risk medication prescriptions from the same medication class on different days.

The intent of the measure is to assess if the reporting provider ordered the high-risk medication(s). If the patient had a high-risk medication previously prescribed by another provider, they would not be counted towards the numerator unless the reporting provider also ordered a high-risk medication for them.

This eCQM is a patient-based measure.

 

This version of the eCQM uses QDM version 5.5. Please refer to the eCQI resource center (https://ecqi.healthit.gov/qdm) for more information on the QDM.

Quality ID 238
Meaningful Measure Medication Management
Telehealth Eligible Yes
Previous Version

Release Notes

Header

  • Updated the eCQM version number.

    Measure Section: eCQM Version Number

    Source of Change: Standards Update

  • Revised the description to add a new rate (rate 2).

    Measure Section: Description

    Source of Change: Measure Lead

  • Revised the measure description to align with the measure intent and guidance.

    Measure Section: Description

    Source of Change: Measure Lead

  • Updated copyright.

    Measure Section: Copyright

    Source of Change: Annual Update

  • Updated the rationale to align with current evidence.

    Measure Section: Rationale

    Source of Change: Measure Lead

  • Updated references.

    Measure Section: Reference

    Source of Change: Standards Update

  • Revised the definition to clarify timing related to the Index Prescription Start Date.

    Measure Section: Definition

    Source of Change: Measure Lead

  • Updated the guidance to clarify the measure intent and support implementation.

    Measure Section: Guidance

    Source of Change: Measure Lead

  • Replaced 'overlaps' or 'overlapping' in the denominator exclusions with plain language to clarify the measure intent.

    Measure Section: Denominator Exclusions

    Source of Change: Measure Lead

  • Updated the Denominator Exclusions to add an exclusion for palliative care.

    Measure Section: Denominator Exclusions

    Source of Change: Measure Lead

  • Revised the numerator to add a new rate (rate 2).

    Measure Section: Numerator

    Source of Change: Measure Lead

  • Revised the numerator to add a new rate (rate 2).

    Measure Section: Numerator Exclusions

    Source of Change: Measure Lead

Logic

  • Added online assessments and telephone visits as appropriate encounters based on the increased use of telehealth services.

    Measure Section: Initial Population

    Source of Change: Measure Lead

  • Updated Denominator Exclusions definition and added PalliativeCare.Palliative Care in the Measurement Period definition to add an exclusion for palliative care.

    Measure Section: Denominator Exclusions

    Source of Change: Measure Lead

  • Revised the numerator logic to add a new rate (rate 2).

    Measure Section: Numerator

    Source of Change: Measure Lead

  • Added exclusion criteria for numerator 2 to align with the American Geriatric Society Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

    Measure Section: Numerator Exclusions

    Source of Change: Measure Lead

  • ​Removed the days supply requirement for nonbenzodiazepine hypnotics by removing the Cumulative Medication Duration requirement for Hypnotics During Measurement Period in the Two High Risk Medications with Prolonged Duration definition and deleting the Hypnotics During Measurement Period definition to align with the American Geriatric Society Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

    Measure Section: Definitions

    Source of Change: Measure Lead

  • Updated Denominator Exclusions definition and added PalliativeCare.Palliative Care in the Measurement Period definition to add an exclusion for palliative care.

    Measure Section: Definitions

    Source of Change: Measure Lead

  • Updated the names of Clinical Quality Language (CQL) definitions, functions, and/or aliases for clarification and to align with the CQL Style Guide.

    Measure Section: Multiple Sections

    Source of Change: Standards Update

  • Removed and added medications to the Same High Risk Medications Ordered on Different Days definition to align with the American Geriatric Society Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

    Measure Section: Multiple Sections

    Source of Change: Measure Lead

  • Updated the version number of the Measure Authoring Tool (MAT) Global Common Functions Library (MATGlobalCommonFunctions-6.2.000). Updated the 'Inpatient Encounter' definition to include a 'day of' timing clarification. Added the following timing functions: Normalize Interval, Has Start, Has End, Latest, Latest Of, Earliest, and Earliest Of. Please see individual measure details for application of specific timing functions.

    Measure Section: Multiple Sections

    Source of Change: Standards Update

  • Added new NormalizeInterval function to timing attributes to decrease implementation burden due to variable use of timing attributes for select QDM data types. The NormalizeInterval function was applied, where applicable, for the following data elements: Assessment, Performed; Device, Applied; Diagnostic Study, Performed; Intervention, Performed; Laboratory Test, Performed; Medication, Administered; Medication, Dispensed; Physical Exam, Performed; Procedure, Performed; Substance, Administered.

    Measure Section: Multiple Sections

    Source of Change: Standards Update

  • Updated Hospice CQL Library to version 3.0.000.

    Measure Section: Multiple Sections

    Source of Change: Measure Lead

  • Added PalliativeCareExclusion CQL library to version 1.0.000.

    Measure Section: Multiple Sections

    Source of Change: Measure Lead

Value Set

The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.

  • Value set Meprobamate (2.16.840.1.113883.3.464.1003.196.12.1284): Deleted 1 RxNorm code (197930) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Trimipramine (2.16.840.1.113883.3.464.1003.196.12.1285): Deleted 6 RxNorm codes (199820, 313497, 245372, 245373, 245374, 250033) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Diphenhydramine (2.16.840.1.113883.3.464.1003.196.12.1293): Deleted 37 RxNorm codes based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Dexchlorpheniramine (2.16.840.1.113883.3.464.1003.196.12.1300): Deleted 7 RxNorm codes (2184088, 1305775, 1357940, 1370680, 2168002, 2184127, 2184130) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Orphenadrine (2.16.840.1.113883.3.464.1003.196.12.1302): Deleted 6 RxNorm codes (994824, 994810, 994811, 994837, 994841, 994847) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Carbinoxamine (2.16.840.1.113883.3.464.1003.196.12.1306): Added 1 RxNorm code (359329) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations. Deleted 6 RxNorm codes (1010946, 1010980, 1012681, 1012956, 1012984, 1424307) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Clemastine (2.16.840.1.113883.3.464.1003.196.12.1308): Deleted 3 RxNorm codes (857452, 857454, 857457) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Disopyramide (2.16.840.1.113883.3.464.1003.196.12.1311): Deleted 3 RxNorm codes (104285, 199730, 199824) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Methyldopa (2.16.840.1.113883.3.464.1003.196.12.1331): Deleted 5 RxNorm codes (104357, 197955, 197959, 197961, 197962) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Trihexyphenidyl (2.16.840.1.113883.3.464.1003.196.12.1334): Deleted 1 RxNorm code (905292) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Clomipramine (2.16.840.1.113883.3.464.1003.196.12.1336): Deleted 5 RxNorm codes (857291, 857296, 857315, 857292, 857326) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Megestrol (2.16.840.1.113883.3.464.1003.196.12.1342): Deleted 1 RxNorm code (860231) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Phenobarbital (2.16.840.1.113883.3.464.1003.196.12.1348): Added 5 RxNorm codes (1046787, 1046815, 1046997, 1048147, 702519) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations. Deleted 14 RxNorm codes based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Dipyridamole (2.16.840.1.113883.3.464.1003.196.12.1349): Deleted 2 RxNorm codes (199314, 392451) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Nifedipine (2.16.840.1.113883.3.464.1003.196.12.1353): Deleted 5 RxNorm codes (199329, 314132, 199782, 391901, 391980) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Desiccated Thyroid (2.16.840.1.113883.3.464.1003.196.12.1354): Deleted 1 RxNorm code (242927) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Imipramine (2.16.840.1.113883.3.464.1003.196.12.1359): Deleted 1 RxNorm code (835586) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Indomethacin (2.16.840.1.113883.3.464.1003.196.12.1366): Deleted 2 RxNorm codes (251255, 392073) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Promethazine Hydrochloride (2.16.840.1.113883.3.464.1003.196.12.1367): Deleted 7 RxNorm codes (861578, 992900, 756160, 992471, 992898, 992904, 992908) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Glyburide (2.16.840.1.113883.3.464.1003.196.12.1368): Deleted 1 RxNorm code (252960) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Carisoprodol (2.16.840.1.113883.3.464.1003.196.12.1369): Deleted 1 RxNorm code (105974) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Methocarbamol (2.16.840.1.113883.3.464.1003.196.12.1370): Deleted 1 RxNorm code (197945) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Removed value set Diphenhydramine Hydrochloride (2.16.840.1.113883.3.464.1003.196.12.1371) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Cyclobenzaprine Hydrochloride (2.16.840.1.113883.3.464.1003.196.12.1372): Deleted 1 RxNorm code (999731) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Dexbrompheniramine (2.16.840.1.113883.3.464.1003.196.12.1375): Added 1 RxNorm code (2391334) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations. Deleted 2 RxNorm codes (1251806, 1305588) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Butabarbital (2.16.840.1.113883.3.464.1003.196.12.1402): Deleted 4 RxNorm codes (1047805, 1251600, 1251610, 1251625) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Triprolidine (2.16.840.1.113883.3.464.1003.196.12.1408): Deleted 2 RxNorm codes (1099711, 996640) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Esterified Estrogens (2.16.840.1.113883.3.464.1003.196.12.1419): Added 2 RxNorm codes (197670, 238006) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations. Deleted 1 RxNorm code (1000353) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Chlorpheniramine (2.16.840.1.113883.3.464.1003.196.12.1352): Added 1 RxNorm code (2383312) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations. Deleted 100 RxNorm codes based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Conjugated Estrogens (2.16.840.1.113883.3.464.1003.196.12.1357): Added 4 RxNorm codes (1000351, 1000352, 1000355, 1000356) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations. Deleted 4 RxNorm codes (1000353, 1000354, 197663, 432572) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Ketorolac Tromethamine (2.16.840.1.113883.3.464.1003.196.12.1364): Added 8 RxNorm codes (1665459, 1665461, 1665675, 1665679,1665682, 860113, 860114, 860115) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations. Deleted 1 RxNorm code (861846) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Estradiol (2.16.840.1.113883.3.464.1003.196.12.1365): Added 2 RxNorm codes (2371764, 2371767) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations. Deleted 5 RxNorm codes (249869, 1000161, 250213, 250838, 483169) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Hydroxyzine (2.16.840.1.113883.3.464.1003.196.12.1374): Deleted 2 RxNorm codes (995428, 995274) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Brompheniramine (2.16.840.1.113883.3.464.1003.196.12.1427): Added 11 RxNorm codes (1357013, 1014331, 1053258, 1090463, 1098497, 1098498, 1111065, 1148155, 1192477, 1244523, 1245722) based on review by technical experts, SMEs, and/or public feedback. Deleted 34 RxNorm codes based on review by technical experts, SMEs, and/or public feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Meperidine (2.16.840.1.113883.3.464.1003.196.12.1351): Added 15 RxNorm codes based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations. Deleted 1 RxNorm code (861578) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Dicyclomine (2.16.840.1.113883.3.464.1003.196.12.1279): Deleted 4 RxNorm codes (991616, 199725, 755900, 991151) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Dimenhydrinate (2.16.840.1.113883.3.464.1003.196.12.1500): Deleted 5 RxNorm codes (1294446, 245357, 245358, 429720, 755901) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Hyoscyamine (2.16.840.1.113883.3.464.1003.196.12.1501): Deleted 5 RxNorm codes (1044608, 1046820, 1047805, 1048078, 1048411) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Meclizine (2.16.840.1.113883.3.464.1003.196.12.1506): Deleted 1 RxNorm code (995682) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Nortriptyline (2.16.840.1.113883.3.464.1003.196.12.1507): Deleted 4 RxNorm codes (199283, 199406, 865143, 865146) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set List of Single RxNorm Code Concepts for High Risk Drugs for the Elderly (2.16.840.1.113883.3.464.1003.196.12.1272): Added 2 RxNorm codes (308170, 318179) based on change in measure requirements/measure specification. Deleted 3 RxNorm codes (860771, 889614, 1363513) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Nonbenzodiazepine hypnotics (2.16.840.1.113883.3.464.1003.196.12.1480): Deleted 2 RxNorm codes (854885, 854886) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Removed value set Amobarbital (2.16.840.1.113883.3.464.1003.196.12.1512) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Butalbital (2.16.840.1.113883.3.464.1003.196.12.1514): Deleted 6 RxNorm codes (197425, 197427, 197428, 240093, 308322, 476152) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Doxylamine (2.16.840.1.113883.3.464.1003.196.12.1515): Deleted 29 RxNorm codes based on validity of code during timing of look back period or based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Removed value set Ergoloid Mesylates (2.16.840.1.113883.3.464.1003.196.12.1516) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Propantheline (2.16.840.1.113883.3.464.1003.196.12.1519): Deleted 1 RxNorm code (312673) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Scopolamine (2.16.840.1.113883.3.464.1003.196.12.1520): Deleted 9 RxNorm codes (1048078, 106507, 199442, 200059, 245350, 250536, 250537, 412723, 429720) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Secobarbital (2.16.840.1.113883.3.464.1003.196.12.1521): Deleted 3 RxNorm codes (308167, 308171, 315201) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set Alcohol Withdrawal (2.16.840.1.113883.3.464.1003.105.12.1209) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set Benzodiazepine (2.16.840.1.113883.3.464.1003.196.12.1522) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set Benzodiazepine Withdrawal (2.16.840.1.113883.3.464.1003.105.12.1208) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set Bipolar Disorder (2.16.840.1.113883.3.464.1003.105.12.1157) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set General Anxiety Disorder (2.16.840.1.113883.3.464.1003.105.12.1210) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set Other Bipolar Disorder (2.16.840.1.113883.3.464.1003.105.12.1204) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set REM Sleep Behavior Disorder (2.16.840.1.113883.3.464.1003.105.12.1207) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set Schizophrenia (2.16.840.1.113883.3.464.1003.105.12.1205) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set Seizure Disorder (2.16.840.1.113883.3.464.1003.105.12.1206) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set Methscopolamine (2.16.840.1.113883.3.464.1003.196.12.1525) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set Telephone Visits (2.16.840.1.113883.3.464.1003.101.12.1080) based on review by technical experts, SMEs, and/or public feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set Online Assessment (2.16.840.1.113883.3.464.1003.101.12.1089) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set Palliative Care Encounter (2.16.840.1.113883.3.464.1003.101.12.1090) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set Palliative Care Intervention (2.16.840.1.113883.3.464.1003.198.12.1135) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added direct reference code CPT code (99211) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added direct reference code LOINC code (71007-9) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

Last Updated: Jul 08, 2021